Immunological status of patients before and after vasovasostomy as determined by the immunobead antisperm antibody test.
With the immunobead antisperm antibody test a prospective study was conducted to evaluate the immune status of 55 men before and after vasectomy reversal. A third of the vasectomy patients (19 of 55) had significant serum-sperm antibodies (20 per cent binding or more) detected by the indirect immunobead antisperm antibody test. Of 31 vasovasostomy patients 12 (38 per cent) had significant sperm-surface antibodies (20 per cent binding or more) by the direct immunobead antisperm antibody test. Preoperative serum assays correctly classified the antibody status of 69 per cent of the vasectomy patients. The immunological impact of spermatic granuloma formation, duration of vasal obstruction, patient age and presence of sperm in the vasal fluid at operation also were assessed. An inverse relationship between the proportion of antibody-bound sperm and the percentage of motile sperm in the ejaculate of vas reversal patients was found with videomicrographic semen analysis. The percentage motility was significantly lower among patients with greater quantities of sperm-surface antibodies. No other parameter of semen analysis showed this difference when compared for positive or negative immunobead antisperm antibody test results.
Broderick
G A
GA
Department of Urology, University of California, San Francisco 94143-0738.
Tom
R
R
McClure
R D
RD
D000328:Adult; D000906:Antibodies / Q000032:analysis*; D006099:Granuloma / Q000276:immunology; D006801:Humans; D007109:Immunity; D007158:Immunologic Techniques / Q000592:standards; D008297:Male; D008863:Microspheres; D008875:Middle Aged; D011184:Postoperative Period; D011237:Predictive Value of Tests; D011446:Prospective Studies; D012680:Sensitivity and Specificity; D013094:Spermatozoa / Q000276:immunology*; D014669:Vasovasostomy
D000906:Antibodies